Therapeia & Co KG - Glioblastoma Program - Ownership and Business Overview

Life ScienceCompany

Therapeia & Co KG - Glioblastoma Program Ownership

Who owns Therapeia & Co KG - Glioblastoma Program?

Therapeia & Co KG - Glioblastoma Program is owned by Telix Pharmaceuticals. It was acquired on January 18, 2017.

Therapeia & Co KG - Glioblastoma Program Business Overview

Where is Therapeia & Co KG - Glioblastoma Program headquartered?

Therapeia & Co KG - Glioblastoma Program is headquartered in Germany.

What sector is Therapeia & Co KG - Glioblastoma Program in?

Therapeia & Co KG - Glioblastoma Program is a life science company.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Therapeia GmbH & Co KG - Glioblastoma Program


Germany,

Therapeia GmbH & Co KG - Glioblastoma Program includes ACD-101 theranostic program for glioblastoma to its pipeline of advanced theranostic radiopharmaceutical products.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 206,228
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Therapeia & Co KG - Glioblastoma Program

Life Science Companies , Germany Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Germany Companies

Largest Germany Companies , Acquisitive Germany Companies , Recently Acquired Germany Companies , Recently Sold Germany Companies , Private Germany Companies , Public Germany Companies , Acquired Germany Companies , PE Backed Germany Companies
Mergr

Product

Company

Legal